Human Vaccines and Immunotherapeutics 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Attitudes toward a future norovirus vaccine among members of an integrated healthcare delivery system in Portland, Oregon, 2016-2017
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 28, 2024 Category: Allergy & Immunology Authors: Holly C. GroomMark SchmidtLaura E. CalderwoodSara A. MirzaClaire MattisonSuzanne SalasJudy DonaldAllison L. Nalewaya Science Programs Department, Kaiser Permanente Center for Health Research, Portland, OR, USAb National Center for Immunization and Respira Source Type: research
Sustainable financing for vaccination towards advancing universal health coverage in the WHO African region: The strategic role of national health insurance
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 28, 2024 Category: Allergy & Immunology Authors: Abdu A. AdamuRabiu I. JaloIbrahim D. MuhammadT éné-Alima EssohDuduzile NdwandweCharles S. Wiysongea Cochrane South Africa, South African Medical Research Council, Cape Town, South Africab Division of Epidemiology and Biostatistics, Department of Global Source Type: research
A systematic literature review of human papillomavirus vaccination strategies in delivery systems within national and regional immunization programs
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 27, 2024 Category: Allergy & Immunology Authors: Marisa FelsherMeheret ShumetCristinela VelicuYa-Ting ChenKinga NowickaMagdalena MarzecGabriela SkowronekIzabela Pieni ążeka Merck & Co., Inc., Rahway, NJ, USAb Arcana Institute, a Certara Company, Krakow, Poland Source Type: research
Prevention of bleomycin-induced pulmonary fibrosis by vaccination with the Tocilizumab mimotope
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 27, 2024 Category: Allergy & Immunology Authors: Jin GuoLin YangHaoming SongLi Baia Department of Cardiorespiratory Rehabilitation, Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), School of Medicine, Tongji University, Shanghai, Chinab Department of Nephrology, Shangh Source Type: research
Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 26, 2024 Category: Allergy & Immunology Authors: Frank van den OuwelandNicola Charpentier Özlem TüreciRuben RizziFederico J. MensaClaudia LindemannShanti Pathera Medical Safety and Pharmacovigilance, BioNTech, Mainz, Germanyb Risk Management, BioNTech, Mainz, Germanyc BioNTech, Mainz, Germanyd Global Source Type: research
Politics and confidence toward the COVID-19 vaccination: A Brazilian cross-sectional study
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 26, 2024 Category: Allergy & Immunology Authors: Marco Antonio Catussi PaschoalottoJoana CimaEduardo CostaSara Valente de AlmeidaJoana Gomes da CostaJo ão Vasco SantosClaudia Souza PassadorJoão Luiz PassadorPedro Pita Barrosa School of Economics and Management, University of Minho, Braga, Portugalb Re Source Type: research
First pediatric B-acute lymphoblastic leukemia patient treated with anti-CD19 chimeric antigen receptor T-cell therapy: Long-term remission or early cure?
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 25, 2024 Category: Allergy & Immunology Authors: Dimitrios BouzianasStella Bouzianaa BReMeL, Biopharmaceutical and Regenerative Medicine Laboratories, Thessaloniki, Greeceb Department of Hematology, King ’s College Hospital, London, UK Source Type: research
The evolution of vaccine hesitancy through the COVID-19 pandemic: A semi-structured interview study on booster and bivalent doses
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 23, 2024 Category: Allergy & Immunology Authors: Jeanna Parsons LeighEmily A. FitzGeraldStephana Julia MossMichal S. CherakRebecca Brundin-MatherAlexandra DoddsHenry T. Stelfox Ève DubéKirsten M. FiestDonna M. HalperinSofia B. AhmedShannon E. MacDonaldSharon E. StrausTerra MancaJosh Ng KamstraAndrea S Source Type: research
Parental willingness of HPV vaccination in Mainland China: A meta-analysis
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 22, 2024 Category: Allergy & Immunology Authors: Sensen TanSumeng WangXunwen ZouXinhua JiaChenyunhao TongJian YinXuemei LianYoulin Qiaoa School of Public Health, Chongqing Medical University, Chongqing, Chinab School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Source Type: research
A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 20, 2024 Category: Allergy & Immunology Authors: Mohamed SerhanAthanasios PsihogiosNooh KabirA. Brianne BotaSalima S. MithaniDavid P. SmithDavid T. ZhuDevon GreysonSarah WilsonDeshayne FellKarina A. TopJulie A. BettingerKumanan Wilsona Clinical Epidemiology Program, Ottawa Hospital Research Institute, O Source Type: research
High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003 –2006 and 2015–2018
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 19, 2024 Category: Allergy & Immunology Authors: Ruth StefanosRayleen M. LewisTroy D. QuerecJulia W. GarganoElizabeth R. UngerLauri E. Markowitza Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USAb Epidemic Source Type: research
Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 19, 2024 Category: Allergy & Immunology Authors: Qiang WangShixin XiuLiuqing YangLan LiMin YangXuwen WangYuan ShenWeibing WangLeesa Lina Department of Epidemiology, School of Public Health, Fudan University, Shanghai, Chinab Department of Immunization, Wuxi Center for Disease Control and Prevention, Wux Source Type: research
Development of a quantitative ELISA for SARS-CoV-2 vaccine candidate, NDV-HXP-S, with CpG 1018 ® adjuvant
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 19, 2024 Category: Allergy & Immunology Authors: Marcus EstradaChangcheng ZhuAnan BzamiJessica A. WhiteManjari LalMedical Devices and Health Technologies, PATH, Seattle, WA, USA Source Type: research
Real-world data of China: Analysis of HPV vaccine coverage and post-vaccination adverse reaction monitoring in Western Chinese provinces from 2018 to 2021
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 19, 2024 Category: Allergy & Immunology Authors: Jing AnYan LiuYingchun MaYong-Zhuo JiaoXue-Feng LiangNa JinJunyi BaoNan JiangXiao-Shu Zhanga Immunization Planning Department, Gansu Provincial Center for Disease Control and Prevention, Lanzhou, Chinab school of public health, Gansu University Of Chinese Source Type: research
Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 16, 2024 Category: Allergy & Immunology Authors: John T. BatesSeth T. LiretteAndrew P. FarmerMichael A. BierdemanKristina B. SeyfarthDallas R. EdererDenise D. MontgomeryGrace C. BurnettAmanda T. PhamGailen D. Marshalla Department of Cell and Molecular Biology, University of Mississippi Medical Center, J Source Type: research
